Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 496 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

NCT02363283

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Colorado Hospital Aurora, Colorado, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

View all 25 locations

View Trial Details

Completed

BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma

NCT01512251

Conditions: BRAF Mutant Metastatic Melanoma, Melanoma, Neoplasms, +10 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial

NCT03158935

Conditions: Advanced Ovarian Cancer, Malignant Melanoma, Melanoma, +11 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma

NCT01425008

Conditions: Melanoma, Metastatic Melanoma, Neoplasm, +12 more
Locations: San Francisco, California, United States

Denver, Colorado, United States

Augusta, Georgia, United States

Indianapolis, Indiana, United States

View all 16 locations

View Trial Details

Completed

Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery

NCT01886235

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +19 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Interpolated Flap Study

NCT04164550

Conditions: Melanoma, Mohs Micrographic Surgery, Neoplasms, +12 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment

NCT03858855

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +20 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

NCT01005472

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations: University of California Los Angeles (UCLA) Los Angeles, California, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma

NCT00039325

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

NCT00090896

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions